#	Pagina
attuale pagina	/open-h2020/projects/226127/index.html
-1	/open-h2020/per-topic/monkeys/list/index.html
-2	/open-h2020/per-topic/sero/list/index.html
-3	/open-h2020/projects/196388/deliverables.html
-4	/open-h2020/projects/206311/index.html
-5	/open-h2020/per-topic/iapp/list/index.html
-6	/open-h2020/per-topic/wk2/list/index.html
-7	/open-h2020/per-topic/nanostructural/list/index.html
-8	/open-h2020/per-topic/occupational/list/index.html
-9	/open-h2020/per-topic/provokes/list/index.html
-10	/open-h2020/projects/210632/results.html

Opendata, web and dolomites

aiVision SIGNED

Innovative AI-based Ophthalmologic Diagnosis

Total Cost €

EC-Contrib. €

Partnership

Views

aiVision project word cloud

Explore the words cloud of the aiVision project. It provides you a very rough idea of what is the project "aiVision" about.

aivision pilots powered 2m ophthalmologists facilitated deep actors team african running orthoptists health 2040 415m company probable incubator grow polytechnique clear syndicate professionals automated market least 640m severe centres suffered patients sight innovation decision 2018 2015 medical retinopathy aiscreenings vastly detection cloud diseases 24 95 screenings orthoptist 60 107 supports france first people hospitals backgrounds willingness 65 blindness start treatment pay french partnership treating examination fundus categorized population platform diabetics diabetic diagnosis telemedicine business figure screening turnover learning signs sciences founded received 15 core improvements database gathered grant diabetes mild eye optimizing 2017 screened ai created algorithms paid 90 suffer intends

Project "aiVision" data sheet

The following table provides information about the project.

Coordinator	AISCREENINGS Organization address address: RUE LEON BOURGEOIS 73 city: PALAISEAU postcode: 91120 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.
Coordinator Country	France [FR]
Total cost	71˙429 €
EC max contribution	50˙000 € (70%)
Programme	1. H2020-EU.3. (PRIORITY 'Societal challenges) 2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs) 3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
Code Call	H2020-SMEInst-2018-2020-1
Funding Scheme	SME-1
Starting year	2019
Duration (year-month-day)	from 2019-12-01 to 2020-03-31

Partnership

Take a look of project's partnership.

#	participants	country	role	EC contrib. [€]
1	AISCREENINGS AISCREENINGS Organization address address: RUE LEON BOURGEOIS 73 city: PALAISEAU postcode: 91120 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	FR (PALAISEAU)	coordinator	50˙000.00

Map

Project objective

AiVision is a unique telemedicine cloud platform powered by deep learning AI that supports the diagnosis of sight related diseases. It is created with the objective of optimizing the detection and treatment of a highly probable cause of blindness in diabetic patients, known as diabetic retinopathy. Diabetic Retinopathy is the leading cause of blindness affecting the population that is less than 65 years old. After 15 years of significant improvements treating diabetes, 95% of type one diabetic patients and 60% of type 2 diabetic patients suffer from at least a mild and in some cases from severe diabetic retinopathy. In 2015, 415m people suffered from diabetes and this figure will grow up to 640m in 2040. There are 4,2M diabetics in the US, and around 24,000 new cases per year of advanced retinopathy due to diabetes. AiVision intends to solve this health problem through an improved eye screening medical examination process facilitated by a telemedicine platform and automated algorithms that support diagnosis decision making. We have gathered a database of more than 107,000 categorized eye fundus screenings which we have use in our algorithms, we have a partnership with the French Orthoptists Syndicate (with 1,000 professionals, it represents 90% of the sector) and are running our first paid pilots in France on 90 hospitals and health centres and working with the WHO in 4 African pilots. There is a clear willingness to pay from the market actors: orthoptist and ophthalmologists consider that the increase in screened patients will vastly contribute to early detection of signs of retinopathy, allowing for better treatment. AiVision is the core project of AiScreenings, a start-up founded in 2017 by partners with management, research, medical sciences and IT backgrounds. The company is based at the Polytechnique Institute business incubator (France). With a team of 9, we have generated our first 100.000€ of turnover in 2018 and received a 90.000€ innovation Grant.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "AIVISION" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "AIVISION" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

Primavera (2018)

Primavera: immunobiotics for treating early stage Age-related Macular Degeneration (AMD)

Colourganisms (2020)

Microbial production of custom-made, pure and sustainable anthocyanins

Woodywood pickering (2019)

Bio-based (fully renewable) cost effective Polymer for new generation of ecological Coatings leveraging a disruptive innovation in the use of Pickering emulsion.